Vanguard Group Inc. Buys 65,478 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Vanguard Group Inc. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 0.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,183,260 shares of the medical instruments supplier's stock after purchasing an additional 65,478 shares during the quarter. Vanguard Group Inc. owned about 10.15% of DENTSPLY SIRONA worth $383,078,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB grew its stake in shares of DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock worth $4,754,000 after purchasing an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. grew its position in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after buying an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp grew its position in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after buying an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after buying an additional 35,360 shares during the period. Finally, Barclays PLC raised its position in shares of DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after buying an additional 54,920 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.52% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on XRAY shares. Mizuho decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Evercore ISI restated an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Finally, Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and a consensus price target of $23.33.

DENTSPLY SIRONA Trading Down 0.3 %

XRAY traded down $0.04 during midday trading on Friday, reaching $13.58. 4,926,034 shares of the company were exchanged, compared to its average volume of 2,926,138. The stock has a market capitalization of $2.70 billion, a P/E ratio of -6.56, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a one year low of $12.54 and a one year high of $33.02. The stock's 50-day simple moving average is $17.14 and its 200 day simple moving average is $19.80. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.71%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.